Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) - Total Liabilities

Latest as of June 2026: CN¥1.81 Billion CNY ≈ $264.24 Million USD

Based on the latest financial reports, Beijing Wantai Biological Pharmacy Enterprise Co Ltd (603392) has total liabilities worth CN¥1.81 Billion CNY (≈ $264.24 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Beijing Wantai Biological Pharmacy Enter's assets to evaluate the company's liquid asset resilience ratio.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Beijing Wantai Biological Pharmacy Enter's balance sheet.

Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors by Total Liabilities

The table below lists competitors of Beijing Wantai Biological Pharmacy Enterprise Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
APT Medical Inc SHG:688617	China	CN¥423.40 Million
TAL Education Group NYSE:TAL	USA	$2.69 Billion
Glarun Technology Co Ltd SHG:600562	China	CN¥3.45 Billion
Coca-Cola Icecek AS IS:CCOLA	Turkey	TL117.96 Billion
Wuxi Taclink Optoelectronics Technology Co. Ltd. A SHG:688205	China	CN¥492.66 Million
Western Superconducting Tech Co Ltd SHG:688122	China	CN¥8.60 Billion
Turkcell Iletisim Hizmetleri AS ORD IS:TCELL	Turkey	TL248.39 Billion
Global Business Travel Group Inc NYSE:GBTG	USA	$3.42 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Beijing Wantai Biological Pharmacy Enterprise Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Beijing Wantai Biological Pharmacy Enter to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.13	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beijing Wantai Biological Pharmacy Enterprise Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beijing Wantai Biological Pharmacy Enterprise Co Ltd (2013–2025)

The table below shows the annual total liabilities of Beijing Wantai Biological Pharmacy Enterprise Co Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.01 Billion ≈ $294.27 Million	-10.28%
2024-12-31	CN¥2.24 Billion ≈ $327.99 Million	-20.83%
2023-12-31	CN¥2.83 Billion ≈ $414.31 Million	-22.74%
2022-12-31	CN¥3.66 Billion ≈ $536.25 Million	+47.56%
2021-12-31	CN¥2.48 Billion ≈ $363.41 Million	+168.98%
2020-12-31	CN¥923.29 Million ≈ $135.11 Million	+58.05%
2019-12-31	CN¥584.19 Million ≈ $85.49 Million	+31.50%
2018-12-31	CN¥444.24 Million ≈ $65.01 Million	-41.30%
2017-12-31	CN¥756.80 Million ≈ $110.74 Million	+52.96%
2016-12-31	CN¥494.76 Million ≈ $72.40 Million	+30.57%
2015-12-31	CN¥378.93 Million ≈ $55.45 Million	+68.27%
2014-12-31	CN¥225.19 Million ≈ $32.95 Million	+0.12%
2013-12-31	CN¥224.92 Million ≈ $32.91 Million	--

About Beijing Wantai Biological Pharmacy Enterprise Co Ltd

SHG:603392 China Biotechnology

Market Cap

$4.88 Billion

CN¥33.35 Billion CNY

Market Cap Rank

#3619 Global

#499 in China

Share Price

CN¥26.38

Change (1 day)

-2.04%

52-Week Range

CN¥24.97 - CN¥58.11

All Time High

CN¥142.90